NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
34.44
-1.81 (-4.99%)
At close: Apr 14, 2026, 4:00 PM EDT
36.47
+2.03 (5.89%)
After-hours: Apr 14, 2026, 7:25 PM EDT

NAMS Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-203.82-241.6-176.94-82-32.52
Depreciation & Amortization
0.220.110.050.070.02
Stock-Based Compensation
59.4333.6224.574.121.19
Other Adjustments
4.3481.985.2373.05-1.65
Changes in Accounts Payable
4.91-12.955.07-2.179.38
Changes in Accrued Expenses
2.451.695.47--
Changes in Unearned Revenue
-2.02-3.95-8.7118.43-
Changes in Other Operating Activities
-13.28-17.464.03-4.46-5.03
Operating Cash Flow
-147.78-158.56-141.227.03-28.62
Capital Expenditures
-0.25-0.67-0.02-0.01-0.02
Purchases of Investments
-296.73-62.18---
Proceeds from Sale of Investments
122.06----
Other Investing Activities
---0.75-
Investing Cash Flow
-174.92-62.85-0.020.73-0.02
Issuance of Common Stock
29.52660.58.91394.3578.46
Repurchase of Common Stock
--0.99---
Net Common Stock Issued (Repurchased)
29.52659.518.91394.3578.46
Other Financing Activities
----0.07-0.01
Financing Cash Flow
29.52659.518.91394.2878.45
Effect of Exchange Rate Changes on Cash and Cash Equivalents
12.76-6.85.055.551.62
Net Cash Flow
-293.18438.1-132.33402.0449.81
Free Cash Flow
-148.03-159.24-141.247.02-28.64
FCF Margin
-657.82%-349.49%-1002.43%6.83%-
Free Cash Flow Per Share
-1.25-1.69-1.720.18-1.21
Levered Free Cash Flow
-211.79-274.83-171.05-70.15-28.18
Unlevered Free Cash Flow
-233.65-209.52-177.1-59.08-29.59
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q